TP53 and cancer: Specifically, H2AFZ overexpression regulates cell cycle signal transduction and DNA replication through pathways involving multiple cancer-associated kinases and E2F1, providing a molecular mechanism explanation for the association between E2F pathway activation and TP53 mutations observed in our high-risk group.